Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-21-350419
Filing Date
2021-12-07
Accepted
2021-12-07 17:18:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d130044d424b3.htm 424B3 30873
2 GRAPHIC g130044g1206110848199.jpg GRAPHIC 4983
  Complete submission text file 0001193125-21-350419.txt   39004
Mailing Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062
Business Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Filer) CIK: 0001817944 (see all company filings)

IRS No.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-259915 | Film No.: 211476843
SIC: 2836 Biological Products, (No Diagnostic Substances)